AIMS: Recent large association studies have revealed associations between genetic polymorphisms and myocardial infarction and coronary heart disease (CHD). We performed a replication study of 10 polymorphisms and CHD in a population with familial hypercholesterolemia (FH), individuals at extreme risk of CHD. METHODS AND RESULTS: We genotyped 10 polymorphisms in 2145 FH patients and studied the association between these polymorphisms and CHD in Cox proportional hazards models. We confirmed the associations between four polymorphisms and CHD, the rs1151640 polymorphism in the olfactory receptor family 13 subfamily G member 1 (OR13G1) gene (HR 1.14, 95% CI 1.01-1.28, P = 0.03), the rs11881940 polymorphism in the heterogeneous nuclear ribonucleoprotein U-like 1 (HNRPUL1) gene (HR 1.27, 95% CI 1.07-1.51, P = 0.007), the rs3746731 polymorphism in the complement component 1 q subcomponent receptor 1 (CD93) gene (HR 1.26, 95% CI 1.06-1.49, P = 0.01), and the rs10757274 polymorphism near the cyclin-dependent kinase N2A and N2B (CDKN2A and CDKN2B) genes (HR 1.39, 95% CI 1.15-1.69, P < 0.001). CONCLUSION: We confirmed previously found associations between four polymorphisms and CHD, but refuted associations for six other polymorphisms in our large FH population. These findings stress the importance of replication before genetic information can be implemented in the prediction of CHD.
AIMS: Recent large association studies have revealed associations between genetic polymorphisms and myocardial infarction and coronary heart disease (CHD). We performed a replication study of 10 polymorphisms and CHD in a population with familial hypercholesterolemia (FH), individuals at extreme risk of CHD. METHODS AND RESULTS: We genotyped 10 polymorphisms in 2145 FHpatients and studied the association between these polymorphisms and CHD in Cox proportional hazards models. We confirmed the associations between four polymorphisms and CHD, the rs1151640 polymorphism in the olfactory receptor family 13 subfamily G member 1 (OR13G1) gene (HR 1.14, 95% CI 1.01-1.28, P = 0.03), the rs11881940 polymorphism in the heterogeneous nuclear ribonucleoprotein U-like 1 (HNRPUL1) gene (HR 1.27, 95% CI 1.07-1.51, P = 0.007), the rs3746731 polymorphism in the complement component 1 q subcomponent receptor 1 (CD93) gene (HR 1.26, 95% CI 1.06-1.49, P = 0.01), and the rs10757274 polymorphism near the cyclin-dependent kinase N2A and N2B (CDKN2A and CDKN2B) genes (HR 1.39, 95% CI 1.15-1.69, P < 0.001). CONCLUSION: We confirmed previously found associations between four polymorphisms and CHD, but refuted associations for six other polymorphisms in our large FH population. These findings stress the importance of replication before genetic information can be implemented in the prediction of CHD.
Authors: Angelique C M Jansen; Emily S van Aalst-Cohen; Barbara A Hutten; Harry R Büller; John J P Kastelein; Martin H Prins Journal: J Clin Epidemiol Date: 2005-03 Impact factor: 6.437
Authors: A C M Jansen; E S van Aalst-Cohen; M W Tanck; M D Trip; P J Lansberg; A H Liem; H W O Roeters van Lennep; E J G Sijbrands; J J P Kastelein Journal: J Intern Med Date: 2004-12 Impact factor: 8.989
Authors: Angelique C M Jansen; Emily S van Aalst-Cohen; Michael W T Tanck; Suzanne Cheng; Marcel R Fontecha; Jia Li; Joep C Defesche; John J P Kastelein Journal: Arterioscler Thromb Vasc Biol Date: 2005-05-05 Impact factor: 8.311
Authors: A Garcia-Rios; P Perez-Martinez; F Fuentes; P Mata; J Lopez-Miranda; R Alonso; F Rodriguez; A Garcia-Olid; J Ruano; J M Ordovas; F Perez-Jimenez Journal: Atherosclerosis Date: 2010-01-22 Impact factor: 5.162
Authors: Jorie Versmissen; Daniëlla M Oosterveer; Mojgan Yazdanpanah; Abbas Dehghan; Hilma Hólm; Jeanette Erdman; Yurii S Aulchenko; Gudmar Thorleifsson; Heribert Schunkert; Roeland Huijgen; Ranitha Vongpromek; André G Uitterlinden; Joep C Defesche; Cornelia M van Duijn; Monique Mulder; Tony Dadd; Hróbjartur D Karlsson; Jose Ordovas; Iris Kindt; Amelia Jarman; Albert Hofman; Leonie van Vark-van der Zee; Adriana C Blommesteijn-Touw; Jaap Kwekkeboom; Anho H Liem; Frans J van der Ouderaa; Sebastiano Calandra; Stefano Bertolini; Maurizio Averna; Gisle Langslet; Leiv Ose; Emilio Ros; Fátima Almagro; Peter W de Leeuw; Fernando Civeira; Luis Masana; Xavier Pintó; Maarten L Simoons; Arend F L Schinkel; Martin R Green; Aeilko H Zwinderman; Keith J Johnson; Arne Schaefer; Andrew Neil; Jacqueline C M Witteman; Steve E Humphries; John J P Kastelein; Eric J G Sijbrands Journal: Eur J Hum Genet Date: 2014-06-11 Impact factor: 4.246